Betaxolol

Half-Life (t½)
PO: 18h
Formula
C18H29NO3
Molecular Weight
307.43 g/mol
PubChem CID
2369
Aliases
Betoptic, Kerlone

Pharmacological Mechanism

Cardioselective β1-adrenergic blocker. Oral form for hypertension; ophthalmic form (Betoptic) for glaucoma — preferred over timolol in patients with respiratory disease due to β1 selectivity reducing bronchospasm risk.

Half-Life & Elimination Curve (PO: 18h)

100%50%25%12.5%0%0h0×t½18h1×t½36h2×t½54h3×t½3d4×t½3.8d5×t½0×t½ (0h): 100% remaining (~19.6 µg/L)1×t½ (18h): 50% remaining (~9.78 µg/L)2×t½ (36h): 25% remaining (~4.89 µg/L)3×t½ (54h): 12.5% remaining (~2.44 µg/L)4×t½ (3d): 6.3% remaining (~1.22 µg/L)5×t½ (3.8d): 3.1% remaining (~0.611 µg/L)
Plasma (PO)t½ Decay (18h)
  • 0×t½0h100% (19.6 µg/L)
  • 1×t½18h50% (9.78 µg/L)
  • 2×t½36h25% (4.89 µg/L)
  • 3×t½54h12.5% (2.44 µg/L)
  • 4×t½3d6.3% (1.22 µg/L)
  • 5×t½3.8d3.1% (0.611 µg/L)
Elimination t½18h (PO)
Rate Constant (ke)0.0385 h⁻¹
Time to Peak (Tmax)4.89h
Est. Peak (Cmax)19.6 µg/L
Clearance (CL)13.9 L/h
97% Washout (5×t½)3.8d

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References